Screener
Recursion Pharmaceuticals, Inc. RXRX Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Recursion Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
FAQ
- What is Recursion Pharmaceuticals, Inc.'s operating margin?
- Recursion Pharmaceuticals, Inc. (RXRX) reported operating margin of -991.7% in Q2 2026.
- How has Recursion Pharmaceuticals, Inc.'s operating margin changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s operating margin increased by 1.4% year-over-year, from -1,005.8% to -991.7%.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s operating margin?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s operating margin has grown at a -16.5% compound annual growth rate (CAGR), from -2,135.7% to -867.9%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Recursion Pharmaceuticals, Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude